PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.99%
Revenue decline while 3141.T shows 10.20% growth. Joel Greenblatt would examine competitive position erosion.
-4.18%
Cost reduction while 3141.T shows 7.16% growth. Joel Greenblatt would examine competitive advantage.
-3.25%
Gross profit decline while 3141.T shows 17.55% growth. Joel Greenblatt would examine competitive position.
0.78%
Margin expansion below 50% of 3141.T's 6.66%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.68%
Other expenses growth 1.1-1.25x 3141.T's 7.36%. Bill Ackman would demand expense justification.
3.12%
Operating expenses growth less than half of 3141.T's 7.36%. David Dodd would verify sustainability.
-2.95%
Total costs reduction while 3141.T shows 7.22% growth. Joel Greenblatt would examine advantage.
-8.33%
Interest expense reduction while 3141.T shows 19.23% growth. Joel Greenblatt would examine advantage.
5.51%
D&A growth 50-75% of 3141.T's 9.47%. Bruce Berkowitz would examine asset strategy.
-15.99%
EBITDA decline while 3141.T shows 45.88% growth. Joel Greenblatt would examine position.
-12.50%
EBITDA margin decline while 3141.T shows 32.37% growth. Joel Greenblatt would examine position.
-27.13%
Operating income decline while 3141.T shows 111.01% growth. Joel Greenblatt would examine position.
-24.11%
Operating margin decline while 3141.T shows 91.47% growth. Joel Greenblatt would examine position.
2.50%
Other expenses growth while 3141.T reduces costs. John Neff would investigate differences.
-25.03%
Pre-tax income decline while 3141.T shows 64.89% growth. Joel Greenblatt would examine position.
-21.91%
Pre-tax margin decline while 3141.T shows 49.63% growth. Joel Greenblatt would examine position.
-23.65%
Tax expense reduction while 3141.T shows 55.51% growth. Joel Greenblatt would examine advantage.
-25.66%
Net income decline while 3141.T shows 70.34% growth. Joel Greenblatt would examine position.
-22.57%
Net margin decline while 3141.T shows 54.56% growth. Joel Greenblatt would examine position.
-25.65%
EPS decline while 3141.T shows 70.23% growth. Joel Greenblatt would examine position.
-25.65%
Diluted EPS decline while 3141.T shows 70.34% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3141.T shows 0.05% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3141.T shows 0.00% change. Joel Greenblatt would examine strategy.